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Role of the GALT in Scrapie Agent Neuroinvasion from
the Intestine1
Bridget R. Glaysher and Neil A. Mabbott2
Following oral exposure, some transmissible spongiform encephalopathy (TSE) agents accumulate first upon follicular dendritic
cells (FDCs) in the GALT. Studies in mice have shown that this accumulation is obligatory for the efficient delivery of the TSE
agent to the brain. However, which GALTs are crucial for disease pathogenesis is uncertain. Mice deficient in specific GALT
components were used here to determine their separate involvement in scrapie agent neuroinvasion from the intestine. In the
combined absence of the GALTs and FDCs (lymphotoxin (LT)/ mice and LT/ mice), scrapie agent transmission was
blocked. When FDC maturation was induced in remaining lymphoid tissues, mice that lacked both Peyer’s patches (PPs) and
mesenteric lymph nodes (wild-type (WT)3LT/ mice) or PPs alone (WT3LT/ mice) remained refractory to disease,
demonstrating an important role for the PPs. Although early scrapie agent accumulation also occurs within the mesenteric lymph
nodes, their presence in WT3LT/ mice did not restore disease susceptibility. We have also shown that isolated lymphoid
follicles (ILFs) are important novel sites of TSE agent accumulation in the intestine. Mice that lacked PPs but contained numerous
FDC-containing mature ILFs succumbed to scrapie at similar times to control mice. Because the formation and maturation status
of ILFs is inducible and influenced by the gut flora, our data suggest that such factors could dramatically affect susceptibility to
orally acquired TSE agents. In conclusion, these data demonstrate that following oral exposure TSE agent accumulation upon
FDCs within lymphoid tissue within the intestine itself is critically required for efficient neuroinvasion. The Journal of Immu-
nology, 2007, 178: 3757–3766.
T ransmissible spongiform encephalopathies (TSEs),3 or“prion diseases,” are subacute neurodegenerative diseasesthat affect humans and both domestic and free-ranging
animals. The neuropathological features within the CNS charac-
teristically include spongiform pathology, neuronal loss, glial ac-
tivation, and amyloidal aggregations of an abnormally folded host
protein. There is little evidence of pathology in other tissues. The
host prion protein (PrPc) is widely expressed in both humans and
animals, and its expression is crucial for TSE disease suscepti-
bility (1). In TSE-affected tissues, the PrP accumulates as an
abnormal, detergent-insoluble, relatively proteinase-resistant
isoform, termed PrPSc. TSE agent infectivity copurifies with
PrPSc (2) and is considered to be a major or possibly sole com-
ponent of the infectious TSE agent. Indeed, the prion hypothesis
argues that PrPSc is itself the infectious agent and facilitates
conversion of cellular PrPc to PrPSc.
TSE diseases typically have long incubation periods before the
onset of clinical signs, which in humans can vary from 1.5 to at
least 40 years. Following peripheral exposure, many of the ac-
quired TSE agents accumulate in lymphoid tissues such as the
spleen, lymph nodes, tonsils, appendix, and Peyer’s patches (PPs),
before spreading to the CNS, a process termed neuroinvasion. Ex-
amples include sheep with natural scrapie (3), mule deer with
chronic wasting disease (4), and humans with variant Creutzfeldt-
Jakob disease (vCJD) (5). Within the lymphoid tissues of both
experimentally and naturally affected hosts, early PrPSc accumu-
lation occurs within the germinal centers upon follicular dendritic
cells (FDCs) and within tingible body macrophages (4–9). FDCs
are a distinct lineage from migratory bone marrow-derived den-
dritic cells because they are considered to derive from stromal
precursor cells, are nonphagocytic, and are nonmigratory (10). In
mouse scrapie models, mature FDCs are critical for scrapie agent
accumulation in lymphoid tissues, and in their absence, neuroin-
vasion is significantly impaired (11–14). From the lymphoid tis-
sues, translocation to the CNS occurs via the peripheral nervous
system (15, 16).
The suggestion that consumption of bovine spongiform enceph-
alopathy-contaminated meat products is the most likely cause of
vCJD in humans (17) has focused attention on the gastrointestinal
tract as an important portal of TSE entry. Following intragastric or
oral inoculation of rodents with scrapie, infectivity and PrPSc ac-
cumulate first in PPs, mesenteric lymph nodes (MLNs), and gan-
glia of the enteric nervous system long before their detection in the
CNS (18, 19). Natural sheep scrapie may also be acquired orally as
PrPSc is detected in the GALT before detection within the CNS (6).
Likewise, PrPSc is first detected in the GALT following experi-
mental oral inoculation of mule deer fawns (Odocoileus hemionus)
with chronic wasting disease (4). The detection of disease-specific
PrP within the GALT of a human vCJD patient 8 mo before the
onset of clinical signs is also consistent with the transmission of
this disease by the oral route (5).
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The GALT comprises chiefly of appendix, tonsils, PPs, MLNs,
and ILFs, but which if any of these tissues are crucial for the oral
pathogenesis of TSEs is unclear. Previous studies have used a va-
riety of immunodeficient mouse lines to study the involvement of
FDCs and PPs in oral scrapie pathogenesis, including TNF-/ 
lymphotoxin (LT)/ mice, aly/aly mice, 7/ mice, RAG-
1/ mice, and MT/ mice (20–22). However, the individual
contributions of the deficiencies in lymphoid tissue, lymphoid tis-
sue microarchitecture, or FDC development were not distinguished
in the same mouse strains. In the current study, mouse models
were created that lacked specific GALT components (PPs, MLNs,
and ILFs) but had mature FDC networks in the remaining lym-
phoid tissues. The presence of FDCs in the remaining lymphoid
tissues ensured that TSE agent accumulation could occur within
these tissues if the missing tissues were not critical to disease
pathogenesis. Using these mouse models, experiments were de-
signed to address the following questions: first, whether TSE sus-
ceptibility is reduced in the absence lymphoid tissue within the
intestine itself (e.g., PPs)? Second, whether neuroinvasion occurs
from multiple sites such that the lack of one compartment (e.g.,
PPs) can be compensated for by the presence of another (e.g.,
MLNs)? Third, whether neuroninvasion can occur via other lym-
phoid tissues (e.g., spleen) in the absence of the GALT?
Materials and Methods
Mice
LT/ mice (23) and LT/ mice (24) were obtained from B&K Uni-
versal and were maintained on a C57BL/6 background. Age- and sex-
matched C57BL/6 mice were used as immunocompetent wild-type (WT)
controls in studies using LT/ mice and LT/ mice.
Gamma irradiation and bone marrow reconstitution
Bone marrow from the femurs and tibias of immunocompetent C57BL/6
WT mice was prepared as a single-cell suspension (3  107–4  107
viable cells/ml) in HBSS (Invitrogen Life Technologies). Recipient adult
(6–8 wk old) LT/ mice, LT/ mice, and C57BL/6 mice were
gamma irradiated (950 rad) and 24 h later reconstituted with 0.1 ml of bone
marrow by injection into the tail vein.
PP-deficient mice
To create progeny mice deficient in PPs, timed pregnant C57BL/Dk mice
were given a single i.v. injection of 100 g of a fusion protein containing
the soluble LTR domain linked to the Fc portion of human IgG1 (LTR-
Ig; Ref 25) on day 11.5 of gestation (26).
Scrapie agent inoculation
For oral inoculation mice were fed individual food pellets doused with 50
l of a 1.0% (w/v) scrapie brain homogenate prepared from mice termi-
nally affected with ME7 scrapie. Where indicated, separate groups of mice
were inoculated by intracranial injection with 20 l of a 1.0% (w/v) scrapie
mouse brain homogenate (containing 1  104.5 ID50 units). Following
challenge, animals were coded and assessed weekly for signs of clinical
disease and killed at a standard clinical end point (27). Scrapie diagnosis
was confirmed by histopathological assessment of vacuolation in the brain.
Where indicated, some mice were sacrificed 70 days postchallenge, and
small intestines, MLNs, and spleens taken for further analysis. For the
construction of lesion profiles, vacuolar changes were scored in nine gray-
matter areas of brain as described previously (28).
Immunohistochemical and immunofluorescent analysis
Spleens and MLNs were removed and snap-frozen at the temperature of
liquid nitrogen. Small intestines from each mouse were divided into three
roughly equal parts, gently squeezed to remove gut contents, coiled, em-
bedded in Tissue-Tek OCT Compound (Bayer), and snap-frozen at the
temperature of liquid nitrogen. Serial frozen sections (10 m in thickness)
were cut on a cryostat. FDCs were visualized by staining with mAb 8C12
to detect CR1 (CD35) or mAb 7G6 to detect CR2/CR1 (CD21/CD35; BD
Biosciences Pharmingen). Complement components C3 and C4 were de-
tected using mAb RMC7H8 (Connex) and mAb FDC-M2 (AMS Biotech-
nology), respectively. Cellular PrPc was detected using PrP-specific poly-
clonal Ab (pAb) 1B3 (29). B lymphocytes were detected using mAb B220
to detect CD45R (Caltag Laboratories). M cells were detected using biotin-
conjugated Ulex europaeus agglutinin I (UEA-1; Vector Laboratories).
Lymphatic vessels were detected using lymphatic vessel endothelial
hyaluronic acid receptor (LYVE-1)-specific antiserum (Upstate Bio-
technology). Nerve fibers and supportive cells were detected using
S100-specific antiserum (DakoCytomation).
For the detection of disease-specific PrP (PrPd) in brain tissue and small
intestines, tissues were fixed in periodate-lysine-paraformaldehyde and em-
bedded in paraffin wax. Sections (thickness, 6 m) were deparaffinized and
pretreated to enhance PrP immunostaining by hydrated autoclaving (15
min, 121°C, hydration), and subsequent immersion in formic acid (98%)
for 5 min (7). This pretreatment enhances the detection of PrPd. Sections
were then stained with the PrP-specific pAb 1B3 (29). Glial fibrillary acid
protein (GFAP) was detected on adjacent brain sections using rabbit
GFAP-specific antiserum (DakoCytomation). To detect FDCs and B lym-
phocytes in paraffin-embedded small intestines, sections were deparaf-
finized and pretreated with Target Retrieval Solution (DakoCytomation)
and immunostained with mAb 7G6 and mAb B220, respectively, as de-
scribed above.
For light microscopy, following the addition of primary Abs, biotin-
conjugated species-specific secondary Abs (Stratech) were applied fol-
lowed by alkaline phosphatase or HRP coupled to the avidin/biotin
complex (Vector Laboratories). Vector Red (Vector Laboratories) and
diaminobenzidine were used as substrates, respectively, and sections were
counterstained with hematoxylin to distinguish cell nuclei. For fluorescent
microscopy, following the addition of primary Ab, species-specific sec-
ondary Abs coupled to Alexa Fluor 488 (green) or Alexa Fluor 594 (red)
dyes (Invitrogen Life Technologies) were used. Sections were mounted in
fluorescent mounting medium (DakoCytomation) and examined using a
Zeiss LSM5 confocal microscope (Zeiss).
ILF enumeration and analysis
Entire small intestines from each mouse were divided into three equal
parts, coiled, fixed in paraformaldehyde, and embedded in paraffin wax.
Serial sections (10 m in thickness) were deparaffinized and immuno-
stained with antisera specific for CD45R or CR2/CR1 as described above
and examined using a confocal microscope. The total number of B lym-
phocyte-containing ILFs in the entire small intestine of each mouse ana-
lyzed was counted microscopically using CD45R expression for identifi-
cation. The maturity of each ILF was determined according to size and the
location and density of component cells as described previously (30). The
presence or absence of FDCs (CR2/CR1CD45R cells) within each ILF
was recorded.
Immunoblot detection of PrPSc
Spleen fragments (20 mg) or MLNs (approximately half the total from
each mouse assayed) were prepared as 10% (w/v) tissue homogenates, and
PrPSc was enriched by sodium phosphotungstic acid precipitation (31) and
treated in the presence or absence of proteinase K (40 g/ml, 60 min, 37°C;
VWR). Following enrichment, pellets were resuspended and diluted to 0.5
mg protein/ml, and 10 l was electrophoresed through SDS-PAGE gels
(12%) polyacrylamide gels (Invitrogen Life Technologies). Proteins were
transferred to polyvinylidene difluoride membranes (Bio-Rad) by semidry
blotting. PrP was detected with the PrP-specific mouse mAb 8H4 (32),
followed by HRP-conjugated goat anti-mouse antiserum. Bound HRP ac-
tivity was detected with Supersignal West Dura Extended Duration Sub-
strate (Pierce).
Statistical analysis
Data are presented as mean  SE. Significant differences between samples
in different groups were sought by one-way ANOVA. Values of p  0.05
were accepted as significant.
Results
Effect of lymphotoxin deficiency on scrapie accumulation in
lymphoid tissues
The intestines of LT/ mice and LT/ mice lack PPs as
LTR signaling during embryonic development is required for
their formation (30, 33, 34). In addition LT/ mice also lack the
MLNs as LT deficiency blocks their formation (34). However,
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postnatal stimulation via lymphocyte-derived LT12 is criti-
cally required to maintain FDCs in their differentiated state
(35). As a consequence, the remaining MLNs and spleens of
LT/ mice (Fig. 1, A and B, respectively) and the spleens of
LT/ mice (Fig. 1B) are deficient in FDCs. Because FDCs
are critical for the efficient neuroinvasion of the ME7 scrapie
agent from the intestine (13), we first investigated scrapie
pathogenesis in the combined absence of GALT (MLNs and/or
PPs) and FDCs in the remaining lymphoid tissues in LT/
mice and LT/ mice.
In this study, the normal cellular form of the PrP is referred to
as PrPc, and two terms (PrPSc or PrPd) are used to describe the
disease-specific, abnormal accumulations of PrP that are charac-
teristically found only in TSE-affected tissues and considered to
represent the presence of the TSE agent (2). Disease-specific PrP
accumulations are relatively resistant to proteinase digestion,
whereas cellular PrPc is destroyed by this treatment. Where we
were able to confirm this resistance by proteinase K treatment of
samples and analysis by immunoblot, PrPSc is used as a biochem-
ical marker for the presence of the TSE agent. Unfortunately, treat-
ment of tissue sections with proteinase K destroys the microarchi-
tecture. Therefore, tissue sections were fixed and pretreated to
enhance the detection of the disease-specific abnormal accumula-
tions of PrP (PrPd), whereas cellular PrPc is denatured by these
treatments (7). We have shown in a series of studies that these PrPd
accumulations occur only in the tissues of TSE-affected animals
and correlate closely with the presence of the TSE agent (7, 8, 11,
13, 19). Expression levels of cellular PrPc in tissues from unin-
fected mice were analyzed on acetone-fixed frozen sections. Im-
munocompetent C57BL/6 WT mice, LT/ mice, and LT/
mice were inoculated orally with the ME7 scrapie strain. Within 70
days of oral inoculation of WT mice with the ME7 scrapie agent,
strong accumulations of PrPd and agent infectivity are found
within PPs (Ref. 13; N. A. Mabbott, unpublished observations).
High levels of proteinase K-resistant PrPSc and agent infectivity
are also found within MLNs (Fig. 2A, lanes 2 and 4; Ref. 13;
N. A. Mabbott, unpublished observations) and are sustained
until the terminal stage of disease (Fig. 2C, lanes 2 and 4).
However, in the MLNs of LT/ mice or the mesenteric mem-
branes taken from MLN-deficient LT/ mice, PrPSc was un-
detectable both 70 days (Fig. 2A) and 545 days (Fig. 2C) after
inoculation. No PrPSc was detected in any of the spleens from
WT mice, LT/ mice, and LT/ mice assayed 70 days
after inoculation (Fig. 2B). However, strong accumulations of
PrPSc were found in the spleens of WT mice taken at the ter-
minal stage of disease (Fig. 2D), but the subsequent accumu-
lation in the spleens of LT/ mice and LT/ mice was
blocked (Fig. 2D). Thus, in the absence of PPs and FDCs in
remaining lymphoid tissues, PrPSc accumulation in MLNs and
the spleen is blocked.
Effect of lymphotoxin deficiency on scrapie susceptibility
We next determined the effect of the combined GALT and FDC
deficiency in LT/ mice and LT/ mice on scrapie suscep-
tibility. All orally inoculated WT mice succumbed to clinical TSE
disease with a mean incubation period of 311  3 days (n  20;
Table I). In contrast, LT deficiency dramatically affected scrapie-
susceptibility as all LT/ mice (n 13) and LT/ mice (n
18) remained free of the signs of scrapie up to at least 545 days
after oral inoculation (Table I). Characteristic PrPd accumulation,
reactive astrocytes, and spongiform pathology were detected in
the brains of all clinically affected WT mice (Fig. 3A). The
severity and distribution of the pathological vacuolation within
the brains of WT mice was typical for oral infection with the
ME7 scrapie strain (Fig. 3B). However, none of the pathological
FIGURE 1. Immunohistochemical detection of FDCs within the MLNs
(A) and spleens (B) of WT mice, LT/ mice, and LT/ mice. CD21/
CD35-expressing (red) FDCs and organized B lymphocyte follicles
(CD45R-positive cells; green) were detected in the tissues of WT mice. No
FDCs were detected in tissues from LT/ mice and LT/ mice. Orig-
inal magnification: 200.
FIGURE 2. PrPSc accumulation in the MLNs and
spleens of LT/ mice and LT/ mice is
blocked following oral inoculation with scrapie. A
and C, MLNs (or the mesenteric membrane contain-
ing the region where MLNs would have been in
LT/ mice) and spleens (B and D) were collected
70 days after oral inoculation with the scrapie agent
(A and B) or at the terminal stage of disease (C and
D). Samples were treated in the presence () or ab-
sence () of proteinase K (PK) before electrophore-
sis. After PK treatment, a typical three-band pattern
was observed between molecular mass values of
20–30 kDa, representing unglycosylated, monogly-
cosylated, and diglycosylated isomers of PrP (in or-
der of increasing molecular mass). dpi, day postin-
oculation on which the tissues were analyzed; pos,
mice that developed clinical signs of scrapie; neg,
mice that were free of the signs of scrapie.
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characteristics of TSE disease were detected within the brains
of any of the surviving LT/ mice and LT/ mice (Fig. 3,
A and B).
When inoculated with the scrapie agent directly into the CNS
(by intracranial injection) WT mice, LT/ mice, and LT/
mice developed clinical scrapie with similar incubation periods
of 172–175 days (Table I). These data confirm that the apparent
resistance of LT/ mice and LT/ mice to orally inocu-
lated scrapie agent could not be attributed to a role for LTR
signaling in the development of pathology within the CNS.
FIGURE 3. Immunohistochemical and pathological analysis of brain tissue from terminally scrapie-affected mice and mice that remained free of the
signs of disease at the end of the experiment. A and B, Brains from WT mice, LT/ mice, and LT/ mice inoculated orally with the scrapie agent.
C and D, Brains from WT3WT mice, WT3LT/ mice, and WT3LT/ mice inoculated orally with the scrapie agent. Large PrPd accumulations
(brown; upper rows), reactive astrocytes expressing high levels of GFAP (red; middle rows), and spongiform pathology (lower rows) were detected in the
hippocampi of all clinically scrapie-affected WT mice (A) and WT3WT mice (C), but not in the brains clinically negative LT/ mice and LT/ mice
(A), and WT3LT/ mice and WT3LT/ mice (C). All sections were counterstained with hematoxylin (blue). Original magnification: 200. dpi,
day postinoculation on which the tissues were analyzed; pos, mice that developed clinical signs of scrapie; neg, mice that were free of the signs of
scrapie. B and D, Pathological assessment of the spongiform change (vacuolation) in brains from terminally scrapie-affected mice and mice that
remained free of the signs of disease at the end of the experiment. Vacuolation was scored on a scale of 0 –5 in the following gray matter (G1–G9)
areas: G1, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus; G7, septum; G8,
retrosplenial and adjacent motor cortex; G9, cingulate and adjacent motor cortex. Each point represents mean vacuolation score  SE for groups
of 6 –20 mice.
Table I. Effect of lymphotoxin deficiency on scrapie agent susceptibility
Mouse Strain
Presence at Time of Inoculation Oral Inoculation Intracranial Inoculation
PPs mILFsa MLNs SPL FDCs Incidenceb
Mean incubation
period (days)  SE Incidence
Mean incubation
period (days)  SE
WT c 5    20/20 311 3 6/6 173 4
LT/  0    0/13 13X 545 5/5 175 4
LT/  0    0/18 18X 545 6/6 172 3
a Number of mILFs present in the small intestine at the time of inoculation.
b Incidence  number of animals affected/number of animals tested. The notation “NX  545” means that mice were free of the clinical and
pathological signs of scrapie up to at least this time after inoculation.
c , present; , absent.
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Reconstitution of LT-deficient mice with WT bone marrow
induces FDC development in remaining lymphoid tissues but not
the development of missing lymphoid tissues
Next, the effects of GALT deficiency, but not FDC deficiency, on
scrapie pathogenesis were investigated. Adult WT mice, LT/
mice, and LT/ mice were reconstituted with LT-expressing
WT bone marrow (termed WT3WT mice, WT3LT/ mice,
and WT3LT/ mice, respectively). Within 35 days of WT
bone marrow transfer, FDC networks were induced in the remain-
ing lymphoid tissues of LT/ mice and LT/ mice (Fig. 4A),
but such treatment did not induce the development of missing lym-
phoid tissues (Table II). Expression of the cellular form of the PrP,
PrPc, upon FDCs within the MLNs (where present) and spleens of
WT3LT/ mice and WT3LT/ mice appeared similar to
that in tissues from WT3WT mice (Fig. 4B).
Scrapie pathogenesis in the absence of MLNs and/or PPs
Groups of WT3WT mice, WT3LT/mice, and WT3LT/
mice were inoculated orally with scrapie 35 days after reconstitu-
tion with WT bone marrow. Strong accumulations of PrPd were
observed within the PPs of WT3WT mice within 70 days of
inoculation (Fig. 5A) and were maintained until the terminal stage
of disease (Fig. 5B). The distribution of the PrPd within PPs was
consistent with accumulation upon FDCs (8, 13). However, PrPd
accumulation within the intestines of WT3LT/ mice and
WT3LT/ mice was blocked (Fig. 5).
In the MLNs, PrPSc was undetectable in tissues from WT3WT
mice, WT3LT/ mice, and WT3LT/ mice assayed 70
days after inoculation (Fig. 6A), although PrPSc was detected in
one of the spleens from a WT3WT mice taken at this time (Fig.
6B, lane 2). At the terminal stage of disease strong accumulations
of PrPSc were found in the MLNs and spleens of WT3WT mice
(Fig. 6, C and D). However, the accumulation of PrPSc in the
MLNs (where present) and spleens of WT3LT/ mice and
WT3LT/ mice remained undetectable (Fig. 6, C and D).
We next determined the effect of MLN and/or PP deficiency on
disease susceptibility. All orally inoculated WT3WT mice suc-
cumbed to clinical TSE disease with a mean incubation period of
337  4 days (n  8, Table II). In contrast, in the absence of both
PPs and MLNs, scrapie susceptibility was dramatically affected as
all orally inoculated WT3LT/ mice (n  8) remained free of
the signs of scrapie up to at least 503 days after inoculation (Table
II). Furthermore, in the absence of PPs alone, scrapie susceptibility
was also dramatically affected as all WT3LT/ mice (n  7)
remained free of clinical scrapie (Table II). Typical neuropatho-
logical characteristics of TSE infection were detected within the
brains of all WT3WT animals that developed clinical signs of
scrapie (Fig. 3, C and D). None of these characteristics were de-
tected within the brains of any of the surviving WT3LT/
mice and WT3LT/ mice (Fig. 3, C and D).
In this study, a highly sensitive immunoblot method was used to
detect PrPSc in our tissue samples (31). Therefore, we are confident
that in this study the combined absence of 1) PrPSc in the GALT
and spleen, 2) PrPd and neuropathological signs within the CNS,
and 3) clinical signs of TSE disease, is convincing evidence that
transmission was blocked in scrapie-inoculated LT/ mice,
LT/ mice, WT3LT/ mice, and WT3LT/ mice.
FIGURE 4. Immunohistochemical analysis of the microarchitecture of
the MLNs and spleen at the time of scrapie challenge. A, CD21/CD35-
expressing (red) FDCs and organized B lymphocyte follicles (CD45R-pos-
itive cells; green) were detected in the MLNs of WT3WT mice and
WT3LT/ mice (upper row) and spleens of WT3WT mice,
WT3LT/ mice, and WT3LT/ mice (lower row). B, The levels
of PrPc expressed upon FDCs (red) were similar in the MLNs of WT3WT
mice and WT3LT/ mice (upper row) and spleens of WT3WT mice,
WT3LT/ mice, and WT3LT/ mice (lower row). Original mag-
nification: 200.
Table II. Reconstitution of LT-deficient mice with WT bone marrow induces FDC maturation in remaining
lymphoid tissues but does not restore susceptibility to orally inoculated scrapie agent
Mouse Straina
Presence at Time of Inoculation Oral Scrapie Inoculation
PPs mILFsb MLNs SPL FDCs Incidence
Mean incubation
period (days)  SE
WT3WT c 0    8/8 337  4
WT3LT/  0    0/8 5X  503d
WT3LT/  0    0/7 4X  503e
a Mice were inoculated orally with the scrapie agent 35 days after gamma irradiation and reconstitution with WT bone
marrow.
b Number of mILFs present in the small intestine at the time of inoculation.
c , present; , absent.
d Three mice were killed 406, 450, and 467 days after inoculation. These mice were free of the clinical signs of scrapie at
the time of cull. No histopathological signs of scrapie were detected in the brain (data not shown).
e Three mice were killed 413, 455, and 455 days after inoculation. These mice were free of the clinical signs of scrapie at
the time of cull. No histopathological signs of scrapie were detected in the brain (data not shown).
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Mature ILFs contain FDCs
Novel lymphoid clusters termed ILFs have been identified along
the antimesenteric wall of the mucosa of the intestine (36). The
maturity of ILFs has previously been defined according size and
the location and density of component cells (30). Whereas imma-
ture ILFs (iILFs) comprise loosely clustered CD45R (B220) cells
located at the base of villi (Fig. 7A), mature ILFs (mILFs) are
organized nodular structures, of width greater than one villus and
comprise a single B lymphocyte follicle (Fig. 7A) with an overly-
ing M cell-containing epithelium similar to the follicle associated
epithelium of PPs (Fig. 7D). Using these criteria, double immu-
nostaining for B lymphocytes (CD45R cells) and FDCs (CR2/
CR1CD45R cells) on the same tissue section revealed that the
presence of FDCs could also be reliably used to distinguish ILF
FIGURE 5. Detection of PrPd in the intestines of
WT3WT mice, WT3LT/ mice, and WT3
LT/ mice following oral inoculation with the
scrapie agent. Small intestines were collected (A) 70
days after oral inoculation or (B) at the terminal stage of
disease. Adjacent sections were stained with CD45R-
specific antiserum B220 to detect B lymphocytes (red),
CD21/35-specific antiserum to detect CR2/CR1-ex-
pressing FDCs (red), and PrP-specific antiserum 1B3
(red). Strong PrPd staining colocalized with CD21/35
expressing FDCs in the PPs and the few mILFs of
WT3WT mice 70 days after oral inoculation (A) and at
the terminal stage of disease (B). PrPd was not detected
in the mILFs of scrapie-inoculated WT3LT/ mice
or WT3LT/ mice. dpi, day postinoculation on
which the tissues were analyzed; pos, mice that devel-
oped clinical signs of scrapie; neg, mice that were free
of the signs of scrapie. Original magnification: 100.
FIGURE 6. PrPSc accumulation in
the MLNs and spleens of WT3
LT/ mice and WT3LT/ mice
is blocked following oral inoculation
with the scrapie agent. A and C,
MLNs (or the mesenteric membrane
containing the region where MLNs
would have been in WT3LT/
mice) and spleens (B and D) were col-
lected 70 days after oral inoculation
with the scrapie agent (A and B) or at
the terminal stage of disease (C and
D). Samples were treated in the pres-
ence () or absence () of proteinase
K (PK) before electrophoresis. dpi,
day postinoculation on which the tis-
sues were analyzed; pos, mice that
developed clinical signs of scrapie;
neg, mice that were free of the signs
of scrapie.
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maturation status. In this study,1000 ILFs were analyzed, and our
data showed that all mILFs consistently possessed large networks of
immune complex-trapping FDCs (Fig. 7, A and B). FDCs were never
detected in iILFs (Fig. 7, A and C). Like PPs, ILFs lack afferent lym-
phatics, but LYVE-1-expressing cells were observed in close associ-
ation with ILFs, indicating the presence of efferent lymphatics (Fig.
7E). S-100-expressing nerve fibers and supportive cells were detected
within the gut wall and in close association with mILFs (Fig. 7F).
Involvement of mILFs in scrapie agent neuroinvasion from the
intestine
Having demonstrated that mILFs contain large FDC networks we
next determined whether scrapie agent neuroinvasion from the in-
testine could also occur from mILFs. Stimulation via LTR is also
important for the development of ILFs as these structures are ab-
sent in LT-deficient mice (30, 36). However, unlike PPs, ILF for-
mation occurs postnatally, and their development in LT-deficient
FIGURE 7. Immunohistochemical characterization of mILFs. A, iILFs
typically comprise a loose aggregation of B lymphocytes at the base of a
villus (CD45R-positive cells; green), whereas mILFs contain both B lym-
phocytes and CR2/CR1-expressing FDCs (CD21/CD35-positive cells;
red). B, Complement components C4 (red; middle) and C3 (red; right) in
association with CR1-expressing FDCs (CD35-positive cells; red; left)
were detected within mILFs indicating the presence of functional FDCs.
(C) In iILFs, CR1-expressing FDCs (CD35-positive cells; red; middle) and
associated C4 (red; right) are absent. D, M cells (UEA-1-positive cells; red;
arrowheads) were detected within the epithelium overlying mILFs. Right
panel shows an enlargement of the boxed area. E, Lymphatic vessels
(LYVE-1-expressing cells; brown) were detected within the cores of villi
(left panel) and within and around mILFs (right panel). F, PrP (green) and
S-100 (red)-expressing nerve fibers, and supportive cells were detected
within the gut wall and in close association with mILFs. In B–E, sections
were counterstained with hematoxylin (blue). Each image is orientated
such that the intestinal lumen is uppermost. Original magnification: 200.
FIGURE 8. Detection of PrPd in the intestines of control mice and PP-
deficient mice following oral inoculation with the scrapie agent. Small
intestines were collected (A) 70 days after oral inoculation or (B) at the
terminal stage of disease. Adjacent sections were stained with CD45R-
specific antiserum B220 to detect B lymphocytes (red), CD21/35-specific
antiserum to detect CR2/CR1-expressing FDCs (red), and PrP-specific an-
tiserum 1B3 (red). At each time point after scrapie inoculation, strong PrPd
staining was found to colocalize with CD21/35-expressing FDCs in the PPs
and the mILFs of control mice and also in the mILFs of PP-deficient mice.
dpi, day postinoculation on which the tissues were analyzed; pos, mice that
developed clinical signs of scrapie; neg, mice that were free of the signs of
scrapie. Original magnification: 100.
Table III. Effect of PP deficiency on susceptibility to orally inoculated scrapie
Mice
Presence at Time of Inoculation Oral Scrapie Inoculation
PPs mILFsa MLNs SPL FDCs Incidence
Mean incubation
period (days)  SE
C57BL/Dk (control) b 2    16/16 319  3
PP deficientc  20    10/10 313  6
a Number of mILFs present in the small intestine at the time of inoculation.
b , present; , absent.
c Mice treated in utero with LTR-Ig on day 11.5 of gestation to ablate PP formation.
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mice can be restored by reconstitution with WT bone marrow (30,
36). In the experiments described above (Table II), no FDC-con-
taining mILFs were present within the intestines of WT3WT
mice, WT3LT/ mice, and WT3LT/ mice at the time of
scrapie inoculation, as these structures take much longer than 35
days to develop after WT bone marrow transfer (8–12 wk; Refs.
30 and 37). The numbers of mILFs in the intestines of immuno-
competent control mice in our specific pathogen-free colony are ex-
tremely low or absent (typically 0–6 mILFs/mouse). However, in the
absence of PPs, LTR stimulation substantially increases the number
of mILFs in the intestine (30). We therefore created mice that lacked
PPs but contained numerous mILFs in their intestines through treat-
ment of pregnant C57BL/Dk mice with LTR-Ig (26, 30). As ex-
pected, PP formation in the progeny mice was blocked (termed PP-
deficient mice), but the development of a significantly greater number
of FDC-containing mILFs was induced when compared with un-
treated C57BL/Dk (control) mice ( p  0.001; Table III).
Control and PP-deficient mice (81–110 days old) were inoculated
orally with the scrapie agent. Strong accumulations of PrPd were ob-
served upon FDCs within each of the numerous mILFs of PP-defi-
cient mice (20 mILFs per PP-deficient mouse, n 14) and the PPs
and occasional mILFs in control mice within 70 days of oral inocu-
lation (Fig. 8A) and at the terminal stage of disease (Fig. 8B). PrPd ac-
cumulations were never observed within iILFs from each mouse group.
In the MLNs, PrPSc was detected in all tissues from control mice
70 days after inoculation, but the levels detected in tissues from
PP-deficient mice were variable (Fig. 9A). However, high levels of
PrPSc levels were detected in MLNs from each mouse group at the
terminal stage of disease (Fig. 9C). No PrPSc was detected in any
of the spleens taken from control mice and PP-deficient mice 70
days after inoculation (Fig. 9B), but strong accumulations were
observed at the terminal stage of disease (Fig. 9D).
Additional experiments demonstrated that the susceptibility of PP-
deficient mice to orally inoculated scrapie agent was not significantly
affected, as all control mice and PP-deficient mice succumbed to clin-
ical TSE disease with similar incubation periods (Table III) and dis-
played similar neuropathological characteristics within the brain (data
not shown). Together, these data imply that FDCs within mILFs are
also important sites of TSE agent neuroinvasion from the intestine.
Discussion
In this study, we show that in the combined absence of the GALT and
FDCs at the time of inoculation, scrapie agent transmission from the
gastrointestinal tract is blocked. Furthermore, when FDC maturation
is induced in remaining lymphoid tissues, mice that lack PPs remain
refractory to oral scrapie challenge. Although the scrapie agent also
accumulates upon FDCs within the MLNs shortly after inoculation,
our data show that MLNs are dispensable for TSE agent neuroinva-
sion from the intestine. We show that mILFs along the antimesenteric
wall of the small intestine contain large FDC networks, and like PPs,
are important sites of TSE agent neuroinvasion. Together, these data
demonstrate that TSE agent accumulation upon FDCs within GALT
in the intestine itself (e.g., PPs and mILFs) is critically required for
efficient neuroinvasion following oral exposure.
When considered in the context of recent studies, our data sug-
gest that TSE agent neuroinvasion from the intestine occurs via the
following pathway. Following oral inoculation, FDCs are critical
initial sites of TSE agent accumulation within the GALT (13). In
the absence of FDCs at the time of inoculation, TSE agent accu-
mulation in the PP and subsequent neuroinvasion are blocked (13).
In the current study, we show that in the absence of PPs, but not
FDCs within other lymphoid tissues, neuroinvasion is likewise
blocked indicating a critical role for PPs and the FDCs within them
in TSE agent neuroinvasion from the intestine. We also show that
mILFs, like PPs, are novel and important sites of TSE agent neu-
roinvasion from the intestine. Because the number and maturation
status of ILFs is dramatically influenced by luminal stimuli (30,
38, 39), our data suggest that the presence of mILFs will signifi-
cantly affect TSE susceptibility. Although early TSE agent accu-
mulation also occurs within the MLNs following oral inoculation,
we demonstrate that their presence does not influence disease
pathogenesis. Likewise, FDCs within the spleen were also unable
to compensate for the absence of the PPs. Together these data
imply that neuroinvasion most likely occurs directly from lym-
phoid tissue within the intestine following accumulation upon
FDCs. This conclusion is congruent with data from an epidemio-
logical, mathematical, and pathological study, which suggested
that for sheep, cattle, and humans, there was an association be-
tween development of lymphoid tissues in the gastrointestinal tract
and susceptibility to natural TSE infection (40). The precise role
that FDCs play in TSE pathogenesis awaits definitive demonstra-
tion, but they appear to amplify the levels of the TSE agent above
the threshold required to achieve neuroinvasion (11–14). When
and how the TSE agent spreads from the FDCs within PPs to the
peripheral nervous system is likewise unknown. FDC depletion 14
days after oral inoculation does not affect pathogenesis, implying
that neuroinvasion occurs from a very early stage postexposure
and before the agent has disseminated to other lymphoid tissues
(13). We show that within mILFs, like PPs (19), FDC networks are
situated in close association with the nerve fibers that run along the
gut wall. As the distance between FDCs and peripheral nerves
appears to modulate the rate of TSE agent neuroinvasion (16), it is
likely that the close association of FDCs with the nerve fibers that
run along the gut wall facilitates the rapid spread of the TSE agent
from PPs and mILFs to neighboring enteric nerves. Indeed, studies
have demonstrated that PrPd accumulates within enteric ganglia
soon after oral inoculation (19).
How TSE agents are initially acquired from the gut lumen and
cross the intestinal epithelium is not known, but several mecha-
nisms have been implicated including transcytosis by M cells (41)
FIGURE 9. PrPSc accumulation in the MLNs and spleens of control
mice and PP-deficient mice following oral inoculation with scrapie. MLNs
(A and C) and spleens (B and D) were collected 70 days after oral inocu-
lation with the scrapie agent (A and B) or at the terminal stage of disease
(C and D). Samples were treated in the presence () or absence () of
proteinase K (PK) before electrophoresis. Lane M contained molecular
mass markers. dpi, day postinoculation on which the tissues were analyzed;
pos, mice that developed clinical signs of scrapie; neg, mice that were free
of the signs of scrapie.
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and possibly also capture and transport by migratory bone marrow-
derived dendritic cells (42). In the current study, any potential
effects on dendritic cell migration to the spleen, due to a lack of
LT12 expressing B lymphocytes (43), were restored by WT
bone marrow reconstitution. However, our data cannot exclude the
possibility that the lack of M cells within the follicle associated
epithelia of LT/ mice, LT/ mice, WT3LT/ mice,
and WT3LT/ mice at the time of inoculation also contributes
to their resistance to orally inoculated scrapie agent.
The inability of the MLNs or spleen to compensate for the ab-
sence of the PPs is unlikely to be due to fundamental differences
in the nature of the FDCs at each of these sites as no significant
differences between the function of FDCs from these tissues has
been described, and each population appears to express similar
levels of PrPc and CR1/CR2. Following oral inoculation, the TSE
agent accumulates first in PPs and is subsequently distributed via
the lymph and/or blood-stream to the MLNs and spleen (Ref. 13
and current study). In the absence of the PPs, our data show that
this down-stream distribution is blocked.
Diet (e.g., consumption of TSE agent-contaminated food) and
PrP genotype (44, 45) are important risk factors that affect TSE
susceptibility, but others remain to be determined. Recent studies
suggest that inflammation may be another factor, either enhancing
agent uptake from mucosal sites (46), or expanding the tissue dis-
tribution of these agents (47–49). For example, the induction of
FDC networks within the ectopic germinal centers of chronically
inflamed kidneys enables the accumulation of high levels of PrPSc
in this tissue and excretion of low levels of infectivity in urine (47,
48). Likewise, natural chronic inflammatory conditions can expand
the deposition of PrPSc in TSE-affected animals, such as to in-
flamed mammary glands of scrapie-affected sheep (49).
ILFs are recently identified lymphoid structures distributed
throughout the intestines of rodents (36, 50–52) and humans (53)
with features similar to PPs. Although the small intestine of an
adult mouse may contain as many as 100 ILFs, data from the
current study and others (30, 37) show that mILFs are highly in-
frequent (typically 5 per mouse) in tissues from unmanipulated
immunocompetent control mice in a specific pathogen-free colony.
Stimulation via LTR is also important for the development of
ILFs, but unlike PPs, their formation occurs postnatally (30, 37). In
response to exogenous stimuli, LT-expressing B lymphocytes trig-
ger the progression of iILFs into mILFs resembling lymphoid nod-
ules containing a single B lymphocyte follicle of predominantly
B2-B lymphocytes with a germinal center and a follicle associated
epithelium containing M cells (30, 37, 54). Our analysis also dem-
onstrates that mILFs consistently contain large FDC networks,
which are not present in iILFs. Because the inducible nature of
mILFs (30, 38) shares features with the ectopically induced ger-
minal centers described above (47–49) we reasoned that mILFs
might represent an important novel site of TSE agent accumulation
and neuroinvasion in the small intestine.
To specifically determine the potential involvement of mILFs in
scrapie agent transmission from the gastrointestinal tract, tempo-
rary in utero blockade of the LTR signaling pathway was used to
create mice that lacked PPs (termed PP-deficient mice), but con-
tained numerous mILFs (26, 30). Our experiments demonstrate
that FDCs within mILFs are novel and important sites of TSE
agent accumulation within the small intestine. Furthermore, due to
the presence of a significantly larger number of FDC-containing
mILFs in PP-deficient mice, disease susceptibility was unaffected
by the absence of PPs. The formation and maturation status of ILFs
can be modulated by both lumenal bacterial flora (30, 38) and
pathogenic microorganisms (39), implying that the microbiologi-
cal status of the intestine at the time of TSE agent exposure might
dramatically enhance disease susceptibility.
In the current study, our animals eat the scrapie agent to model
oral pathogenesis as closely as possible. Following ingestion of the
scrapie agent many factors will act on the inoculum to aid its
elimination from the host. Indeed, much of the inoculum will be
eliminated from the host by factors including digestion (by en-
zymes secreted in the stomach or small intestine) and excretion. As
a consequence, following oral inoculation very little of the original
inoculum will be available to be translocated across the gut epi-
thelium by M cells or other potential mechanisms (41, 42). In WT
mice it is likely that once the remaining fraction of the inoculum
enters the lamina propria a competitive state exists whereby cells
such as macrophages aid the clearance of the TSE agent (55, 56),
whereas FDCs act to expand the levels of the TSE agent above the
threshold required to achieve neuroinvasion. Thus, in the absence
of FDCs (and lymphoid tissue within the intestine) in LT-deficient
mice, the residual fraction of the inoculum will be gradually de-
stroyed by phagocytic cells (55, 56). We have previously shown
that the temporary depletion of FDCs for21–28 days blocks TSE
agent transmission from the intestine (13), suggesting this time
interval is sufficient to allow clearance of the remaining inoculum.
In the current study, no mILFs were detected in the small intestines
of WT3LT/ mice and WT3LT/ mice at the time the
mice were inoculated with the scrapie agent (5 wk after bone mar-
row reconstitution) as their formation occurs between 8 and 12 wk
after WT bone marrow reconstitution (30, 37). Therefore, by the
time the mILFs had eventually developed in the intestines of
WT3LT/ mice and WT3LT/ mice, sufficient time will
have elapsed to allow clearance of the remaining inoculum, pre-
venting PrPd accumulation upon the FDCs within them and sub-
sequent neuroinvasion.
In conclusion, our data demonstrate the crucial importance of
TSE agent accumulation upon FDCs within the GALT for efficient
neuroinvasion following oral exposure. Current evidence suggests
vCJD shares a similar requirement for accumulation upon FDCs
before neuroinvasion (5). Thus, our data imply that neuroinvasion
of the vCJD agent might also occur soon after accumulation within
the GALT before the agent has disseminated to other lymphoid
tissues. Our data also identify mILFs as a novel and important site
of TSE agent accumulation within the small intestine. As the for-
mation and maturation status of ILFs is strongly influenced by
commensal and pathogenic microorganisms (30, 38, 39), factors
that stimulate mILF development are likely to dramatically en-
hance susceptibility to orally acquired TSE agents.
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